PetLife Pharmaceuticals, Inc. Proceeds from Secured Notes Payable
PetLife Pharmaceuticals, Inc. reported Proceeds from Secured Notes Payable of $67.60 thousand for the 43-month period ending 2014-05-31, per its 10-Q filed 2014-08-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromSecuredNotesPayable · last filed 2014-08-05
- PetLife Pharmaceuticals, Inc. proceeds from secured notes payable for fiscal 2012 was $67.60K.
| Period end | Proceeds from Secured Notes Payable 12 month | Proceeds from Secured Notes Payable 34 month | Proceeds from Secured Notes Payable 37 month | Proceeds from Secured Notes Payable 40 month | Proceeds from Secured Notes Payable 43 month |
|---|---|---|---|---|---|
| 2014-05-31 | $67.60K 10-Q · filed 2014-08-05 | ||||
| 2014-02-28 | $67.60K 10-Q · filed 2014-08-05 | ||||
| 2013-11-30 | $67.60K 10-Q · filed 2014-08-05 | ||||
| 2013-08-31 | $67.60K 10-K · filed 2014-07-21 | ||||
| 2012-08-31 | $67.60K 10-K · filed 2014-07-21 |